NAMS vs QURE: Side-by-Side Comparison
Compare NewAmsterdam Pharma Company NV (NAMS) and uniQure N.V. (QURE) side by side: market cap USD 4.07B vs USD 2.64B. Financials, growth and model signals on Bullrun.
| Metric | NAMS | QURE |
|---|---|---|
| Company | NewAmsterdam Pharma Company NV | uniQure N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.07B | USD 2.64B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 22.50M | USD 16.10M |
| Revenue growth YoY | -50.6% | -40.6% |
| Net income | USD -203.00M | USD -199.00M |
| Gross margin | — | 89.5% |
| Diluted EPS | -1.72 | -3.46 |